What question did this study set out to answer?

The aim is to evaluate the efficacy of DaraEx in resolving false-positive antibody screenings induced by daratumumab.

March 21, 2026

Effective resolution of daratumumab‐induced false‐positive antibody screening with commercial reagents

Key Points

The aim is to evaluate the efficacy of DaraEx in resolving false-positive antibody screenings induced by daratumumab.
Comparison of DaraEx and DTT in antibody screening
Assessment of interference in antibody tests
Evaluation of safety and efficiency of commercial reagents
DaraEx completely removed DARA-related interference
DaraEx was effective even when DTT failed
DaraEx is a safe alternative for pre-transfusion antibody screening

Abstract

DaraEx consistently and completely removed DARA-related interference, including in cases where DTT was ineffective. It represents a safe and efficient alternative to DTT for pre-transfusion antibody screening.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Han Joo Kim

Suk Won Seo

Yousun Chung

Journals

Vox Sanguinis

Actions

Institutions

University of Ulsan

Seoul National University Hospital

Kangdong Sacred Heart Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Effective resolution of daratumumab‐induced false‐positive antibody screening with commercial reagents

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider